← All stocks

Travere Therapeutics, Inc.

TVTX Mostly scheduled

CIK 0001438533 #1223 in the set updated 17 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$2.02M

$0.00 on a plan · $1.98M straight out of an exercise

Sold at will

$42.61K

1 of 10 sales

Net

−$2.02M

−$42.61K against sales at will

By person

16 insiders · 10 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Meckler Jeffrey A

Director

—

$1.35M (4) scheduled

−$1.35M

91,500

0.0971%

$6.23M

+13.0%

LYONS GARY A

Director

—

$632.85K (5) scheduled

−$632.85K

61,500

0.0652%

$4.19M

+20.6%

Cline Christopher R.

CHIEF FINANCIAL OFFICER

—

$42.61K (1)

−$42.61K

118,016

0.1252%

$8.04M

+58.2%

Dube Eric M

CHIEF EXECUTIVE OFFICER

—

432,886

0.4592%

$29.47M

+19.6%

Heerma Peter

CHIEF COMMERCIAL OFFICER

—

140,684

0.1492%

$9.58M

+30.3%

ROTE WILLIAM E.

Chief Research Officer

—

115,474

0.1225%

$7.86M

+33.0%

Inrig Jula

CHIEF MEDICAL OFFICER

—

112,770

0.1196%

$7.68M

+82.0%

REED ELIZABETH E

Chief Legal Officer and GC

—

105,211

0.1116%

$7.16M

+31.3%

Coughlin Timothy

Director

—

56,250

0.0597%

$3.83M

+14.8%

Calvin Sandra

SVP, CHIEF ACCOUNTING OFFICER

—

42,353

0.0449%

$2.88M

−18.6%

Baynes Roy D.

Director

—

41,500

0.0440%

$2.83M

+33.9%

Squarer Ron

Director

—

39,375

0.0418%

$2.68M

+36.4%

Orwin John A

Director

—

39,375

0.0418%

$2.68M

+36.4%

Poole Sandra

Director

—

34,000

0.0361%

$2.31M

+44.7%

Bruhn Suzanne Louise

Director

—

32,750

0.0347%

$2.23M

+47.2%

Williams Brinkley Ruth

Director

—

29,750

0.0316%

$2.03M

+54.5%

Individual transactions

Insider

Date

Role

Action

Price

Amount

Meckler Jeffrey A

10 Sep 2026

Director

Sold after exercise

3,100

$68.09

$211.07K

Meckler Jeffrey A

10 Sep 2026

Director

Sold after exercise

14,000

$67.46

$944.49K

Meckler Jeffrey A

10 Sep 2026

Director

Sold after exercise

1,200

$66.15

$79.38K

Meckler Jeffrey A

10 Sep 2026

Director

Sold after exercise

1,700

$65.39

$111.17K

Cline Christopher R.

2 Sep 2026

CHIEF FINANCIAL OFFICER

Sell

642

$66.37

$42.61K

LYONS GARY A

18 Aug 2026

Director

Sold after exercise

900

$63.86

$57.47K

LYONS GARY A

18 Aug 2026

Director

Sold after exercise

4,100

$63.27

$259.39K

LYONS GARY A

17 Aug 2026

Director

Sold after exercise

500

$64.16

$32.08K

LYONS GARY A

17 Aug 2026

Director

Sold after exercise

2,600

$63.50

$165.10K

LYONS GARY A

17 Aug 2026

Director

Sold after exercise

1,900

$62.53

$118.80K

What was left out

Form 4 filings counted 3

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 9

Sales at will 1

Transactions with no price 0

Shares from compensation/vesting 30,000

History held since 2 Sep 2016